Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses-Reference-Cited by-同舟云学术

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

Published:2009-02-22 Issue:3 Volume:16 Page:265-273
ISSN:1545-9993
Container-title:Nature Structural & Molecular Biology
language:en
Short-container-title:Nat Struct Mol Biol

Author:

Sui Jianhua,Hwang William C,Perez Sandra,Wei Ge,Aird Daniel,Chen Li-mei,Santelli Eugenio,Stec Boguslaw,Cadwell Greg,Ali Maryam,Wan Hongquan,Murakami Akikazu,Yammanuru Anuradha,Han Thomas,Cox Nancy J,Bankston Laurie A,Donis Ruben O,Liddington Robert C,Marasco Wayne A

Publisher

Springer Science and Business Media LLC

Subject

Molecular Biology,Structural Biology

Link

http://www.nature.com/articles/nsmb.1566.pdf

Reference61 articles.

1. WHO. Factsheet 211: influenza. World Health Organization 〈 http://www.who.int/mediacentre/factsheets/2003/fs211/en/ 〉 (2003).

2. Webster, R.G. 1918 Spanish influenza: the secrets remain elusive. Proc. Natl. Acad. Sci. USA 96, 1164–1166 (1999).

3. de Wit, E. & Fouchier, R.A. Emerging influenza. J. Clin. Virol. 41, 1–6 (2008).

4. WHO. Global influenza surveillance. World Health Organization 〈 http://www.who.int/csr/disease/influenza/influenzanetwork/en/index.html 〉 (2008).

5. Carrat, F. & Flahault, A. Influenza vaccine: the challenge of antigenic drift. Vaccine 25, 6852–6862 (2007).

Cited by 1013 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting neuraminidase: the next frontier for broadly protective influenza vaccines;Trends in Immunology;2024-01

2. Broadly neutralizing antibodies to combat influenza virus infection;Antiviral Research;2024-01

3. Poultry Vaccine Technology Platforms;Avian Diseases;2023-12-12

4. Monoglycosylated SARS-CoV-2 receptor binding domain fused with HAstem-scaffolded protein vaccine confers broad protective immunity against SARS-CoV-2 and influenza viruses;Antiviral Research;2023-12

5. Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses;Journal of Virology;2023-11-30